Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022
- PMID: 40597768
- PMCID: PMC12211491
- DOI: 10.1186/s12885-025-14474-5
Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022
Abstract
Background: Though studies reported factors determining cervical cancer screening, investigating community-level determinants was limited and not conclusive. This study included both individual- and community-level indicators to investigate factors affecting cervical cancer screening nationwide in Kenyan reproductive-age women.
Methods: The 2022 Kenyan Demography and Health Survey data was used for the study. A total of 16,716 reproductive-age women were included in the analysis. A multilevel analysis using generalized linear mixed models with the log-binomial function was applied to examine the association between individual- and community-level factors with cervical cancer screening. The goodness of a fit model was identified by using deviance, and the model with the lowest deviance was considered as the best-fitted model. Adjusted odds ratio (AOR) with its 95% confidence interval (CI) at p-value < 0.05 was used to declare significantly associated factors with women's cervical cancer screening.
Results: The pooled prevalence of cervical cancer screening in Kenya was 7.40% (95% CI: 7.02%, 7.78%). Women's age, marital status, educational status, wealth index, employment status, media exposure, parity, contraceptive use, visited health facility last 12 months, self-reported sexually transmitted disease, and geographical zone were significantly associated with cervical cancer screening.
Conclusions: Policies should give emphasis to community-based education, health insurance coverage to overcome the financial burden of the community, create opportunities for women`s employment, strengthen media exposure to educate women, and increase the coverage of contraceptive use. Moreover, infrastructure accessibility and awareness creation on the benefits of facility visits and medical checkups could improve cervical cancer screening in Kenya.
Keywords: Cervical cancer; Cervical cancer screening; Kenya; Kenya demographic and health surveys; Multilevel analysis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All data were obtained from the 2022 KDHS. Informed consent was obtained from each respondent before the interviews. Procedures and questionnaires for standard DHS surveys have been reviewed and approved by the ICF International Institutional Review Board (IRB). We obtained approval to use the data from the DHS repository, http://www.dhsprogram.com. The original KDHS protocol was reviewed and approved by the Kenyan Medical Research Institute (KEMRI) Ethical review committee, affiliated with the Kenyan Medical Research Institute. The study adhered to the principles of the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data.BMC Public Health. 2025 Jul 4;25(1):2385. doi: 10.1186/s12889-025-23593-4. BMC Public Health. 2025. PMID: 40615793 Free PMC article.
-
Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: A multilevel data analysis of the 2022 Kenyan Demographic and Health Survey.PLoS One. 2025 Aug 1;20(8):e0329458. doi: 10.1371/journal.pone.0329458. eCollection 2025. PLoS One. 2025. PMID: 40748912 Free PMC article.
-
Cervical cancer screening uptake in Côte d'Ivoire: Analysis of prevalence and associated factors.BMC Public Health. 2025 Jul 2;25(1):2287. doi: 10.1186/s12889-025-23103-6. BMC Public Health. 2025. PMID: 40604672 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Forouzanfa M, Delossantos FK, Lozano A, Lopez R, Murray A, Mohsen J. Naghavi., Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. www.thelancet.com October 22, 201, 2015. 387. - PubMed
-
- WHO, Bank UNTW, Globocan IARC. Cervical Cancer Global Crisis Card.http://www.who.int/hpvcentre/statistics/en/., (2013).